Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Eddie Chung

Message the company or request a 1:1 meeting here

Coastar Therapeutics’ revolutionary journey began in 2017. At that time, oncolytic virus and gene therapy had gained a lot of traction. But as promising as this therapy was, one of the key challenges had yet to be overcome: immune clearance of the virus. Coastar Therapeutics was then launched to overcome this tremendous issue, paving the way for superior oncolytic virus therapy in cancer patients.

Executive Summary